Longitudinal follow-up of growth/development/physical health of children treated as newborns for persistent pulmonary hypertension (PPHN) with inhaled nitric oxide (iNO), high frequency ventilation (HFV), extracorporeal membrane oxygenation (ECMO). There is also a control group not treated with those modalities. Finally, there is a group treated for conginital heart disease with heart transplant. The goal of the protocol is to evaluate long term results in neonates treated with novel therapies.
Showing the most recent 10 out of 837 publications